MRI Scan — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Magnetic resonance imaging (MRI) is a non-invasive diagnostic imaging modality that uses powerful static magnetic fields, radiofrequency pulses, and sophisticated computer processing to generate detailed cross-sectional images of internal body structures without any ionising radiation. Unlike X-rays and CT scans which use radiation, MRI exploits the magnetic properties of hydrogen protons — abundant in all biological tissues as constituents of water and fat — to generate tissue-specific contrast. When placed in a strong magnetic field (typically 1.5 or 3 Tesla in clinical scanners, compared with the Earth's field of 0.00005 Tesla), hydrogen protons align with the field. A radiofrequency pulse at the resonant frequency of these protons flips their alignment; as protons relax back to equilibrium, they emit radiofrequency signals with characteristic T1 (longitudinal) and T2 (transverse) relaxation time constants that differ between tissue types — fat, water, muscle, cartilage, fibrous tissue, and pathological tissue each produce distinct signal intensities. This differential relaxation produces the superior soft tissue contrast that distinguishes MRI from all other imaging modalities. Different pulse sequences — T1-weighted, T2-weighted, proton density, STIR (short tau inversion recovery for fat suppression), DWI (diffusion-weighted imaging), FLAIR (fluid-attenuated inversion recovery) — are selected by the radiologist to optimise contrast for different anatomical regions and pathologies. Modern 3 Tesla scanners produce high-resolution images with shorter scan times, while 7 Tesla research scanners and open MRI systems (0.5–1 Tesla) address specific clinical needs. MRI is performed by radiographers under radiologist supervision and images are reported by a consultant radiologist.

MRI is the imaging investigation of choice for a wide range of anatomical regions and clinical indications across all medical specialties where superior soft tissue contrast, multiplanar capability, and absence of radiation are advantageous. Brain and spinal cord: MRI is the gold standard for evaluation of brain tumours (primary and metastatic), multiple sclerosis (MS plaques on FLAIR and T2 sequences), acute stroke (diffusion-weighted imaging identifies ischaemia within minutes), encephalitis, pituitary tumours, acoustic neuromas, posterior fossa pathology poorly seen on CT, epilepsy focus evaluation, cavernous malformations, and spinal cord demyelination, tumours, and vascular malformations. Musculoskeletal: MRI is indispensable for assessment of ligament and tendon tears (anterior cruciate ligament, rotator cuff), cartilage pathology and chondral defects, labral tears (hip and shoulder), meniscal tears, stress fractures not visible on plain radiography, osteonecrosis, bone marrow lesions, and soft tissue tumour characterisation. Cardiac MRI (CMR) provides comprehensive cardiac function, viability, and morphology assessment including myocarditis, cardiomyopathies, congenital heart disease, and cardiac masses. Abdominal and pelvic: MRI characterises liver lesions (HCC, metastases, haemangioma, focal nodular hyperplasia) with MRCP replacing invasive ERCP for biliary and pancreatic duct imaging; prostate cancer staging uses multiparametric MRI (mpMRI) with T2, DWI, and DCE sequences; rectal cancer local staging guides neoadjuvant treatment; and gynaecological imaging (endometrial, cervical, ovarian cancer staging) is superior to CT for soft tissue detail. Breast MRI is used for high-risk screening in BRCA1/2 carriers, extent-of-disease assessment before surgery, and monitoring response to neoadjuvant chemotherapy. Contraindications include certain non-MR-conditional metallic implants, non-conditional cardiac pacemakers and defibrillators, and cochlear implants — all must be verified before scanning.

Before the scan, patients complete a comprehensive MRI safety screening questionnaire identifying metallic implants, electronic devices, previous surgery, and known contraindications to MRI. All ferromagnetic metallic objects must be removed — jewellery, piercings, hairpins, clothing with metallic components, and hearing aids. An intravenous cannula is inserted if gadolinium contrast will be used. The patient lies supine on a motorised table that slides into the bore of the cylindrical MRI magnet. A radiofrequency (RF) coil — a dedicated antenna designed for the body region being scanned — is positioned around or over the anatomical area of interest. Different coils are used for the brain (head coil), spine (spinal array), knee, shoulder, wrist, and abdomen. The MRI radiographer programmes the scan sequences, which include multiple image series with varying tissue contrasts. The machine produces loud repetitive knocking and thumping noises (30–130 decibels) from gradient coil switching during scanning — patients are given earplugs or headphones with music to manage this. The scan table advances and retracts through the magnet bore during image acquisition. Patients must remain completely still during each sequence — even small movements degrade image quality significantly. The scan duration is 20–45 minutes for a single region without contrast, extending to 60–90 minutes for complex multi-region or contrast-enhanced studies. Gadolinium-based contrast agent (GBCA) — administered as a rapid intravenous injection (0.1 mmol/kg body weight) — is used in approximately 50% of clinical scans to enhance blood vessels, break down in blood-brain barrier disruption (tumours, active MS plaques, infection), characterise liver lesions, and assess inflammatory activity. Images are transferred to a PACS (picture archiving and communication system) workstation for reporting by a radiologist within 24–72 hours for routine studies or immediately for urgent emergency scans.

MRI offers several clinically important advantages over other imaging modalities that make it the preferred investigation in numerous clinical settings. Superior soft tissue contrast: MRI distinguishes between tissue types that appear identical on CT — grey and white matter in the brain, cartilage vs subchondral bone in joints, endometrium vs myometrium in the uterus, and soft tissue tumour subtypes. This contrast superiority translates to diagnostic sensitivity of 85–95% for musculoskeletal pathology and over 95% for brain lesions including small metastases and early MS plaques. No ionising radiation: MRI uses no X-rays or gamma radiation, making it the investigation of choice for repeated imaging, for children and pregnant women, and for young patients with conditions requiring long-term surveillance (MS, sickle cell disease, haemophilia, epilepsy). CT delivers a radiation dose of 2–15 mSv per scan — equivalent to 1–7 years of background radiation — whereas MRI delivers none. Multiplanar capability without repositioning: MRI can acquire images in any plane — axial, coronal, sagittal, oblique — from a single scan without repositioning the patient, unlike CT (primarily axial) or radiographs. Functional imaging: diffusion-weighted imaging (DWI) quantifies the restriction of water molecule movement in tissues, enabling early detection of acute stroke (within minutes of onset), differentiation of abscess from necrotic tumour, and assessment of tumour cellularity. Dynamic contrast-enhanced MRI characterises tissue vascularity for tumour grading. MR spectroscopy analyses metabolite profiles in the brain. MR perfusion and arterial spin labelling measure cerebral blood flow without contrast. These functional techniques are not available with CT or ultrasound.

MRI is inherently safe when safety protocols are rigorously followed, as it uses no ionising radiation and the biological effects of the magnetic field are not known to be harmful at clinical field strengths. However, specific risks and contraindications must be carefully managed. Gadolinium contrast reactions occur in approximately 0.1–0.5% (mild, including urticaria and nausea) and severe anaphylaxis in under 0.01%; a resuscitation team and anaphylaxis kit must be immediately available during all contrast-enhanced scans. Nephrogenic systemic fibrosis (NSF) — a rare but serious fibrosing condition affecting skin, joints, and internal organs — has been reported almost exclusively with older linear gadolinium agents in patients with severe renal impairment (eGFR below 30 mL/min/1.73m²); modern macrocyclic gadolinium agents (gadobutrol, gadoterate meglumine, gadoteridol) have an extremely low NSF risk and are preferred. Gadolinium retention in brain tissue (particularly dentate nuclei) has been detected on MRI in patients receiving multiple contrast administrations; the clinical significance of this retention is currently uncertain but under active investigation. All gadolinium-based contrast requires renal function assessment (eGFR measurement within 3 months) before administration. Metallic implant safety: ferromagnetic metal objects in the magnetic field may heat, move, or interfere with electronic function. All implants must be checked against the implant MR safety database (implantinfo.com) before scanning. Traditional cardiac pacemakers are a contraindication to MRI; most modern devices implanted after 2011 are MR-conditional at 1.5T under specified conditions. Cochlear implants, drug infusion pumps, and neurostimulators require device-specific safety checking. Patients with severe claustrophobia may require sedation. Scan duration (20–90 minutes of immobility) can be challenging for children, the elderly, and patients in pain — general anaesthesia or deep sedation may be required for these groups.

MRI requires no recovery time whatsoever for patients without contrast or sedation — they can drive, work, and resume all activities immediately after the scan. Gadolinium contrast is renally cleared by glomerular filtration within 24 hours in patients with normal renal function (eGFR above 60 mL/min/1.73m²); adequate hydration (2–3 litres of water over the 24 hours following injection) accelerates clearance and reduces gadolinium tissue retention. Patients receiving intravenous sedation (midazolam or propofol) for claustrophobia management must not drive for 24 hours and require an accompanying adult escort home. Children who receive general anaesthesia for MRI are observed in the recovery area until fully awake before discharge with appropriate post-anaesthetic instructions. Any symptoms of delayed contrast reaction — urticaria, rash, breathing difficulty — in the hours following gadolinium administration should prompt urgent medical review. Patients with renal impairment receiving gadolinium are counselled that prolonged hydration and monitoring of renal function at 48–72 hours may be appropriate for higher-risk macrocyclic agents in borderline renal function cases. Report results — communicated by the referring clinical team, usually within 24–72 hours for routine studies and within hours for urgent clinical indications — form the basis for subsequent management decisions. Patients with claustrophobia who struggled with the scan are often counselled on strategies for future scans: anxiolytic pre-medication, wide-bore 3T scanners, or open MRI systems. Diagnostic MRI reports are formally issued by a consultant radiologist and communicated to the referring clinician who discusses results with the patient.